Results 201 to 210 of about 66,181 (261)

Targeting of tripartite neuron-cancer-immune cell crosstalk augments response to chemotherapy and immunotherapy. [PDF]

open access: yesCell Rep Med
Jain D   +31 more
europepmc   +1 more source

Bispecific antibodies targeting B‐cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions

open access: yesCancer, Volume 132, Issue 22, 15 November 2026.
Abstract Anti‐B cell maturation antigen (BCMA) therapies, including antibody‐drug conjugates, chimeric antigen receptor T cells, and bispecific antibodies (bsAbs), have recently revolutionized the treatment landscape of multiple myeloma. This review outlines the biologic rationale for targeting BCMA and sheds light on the mechanism of action of bsAbs ...
Enrica Manzato   +5 more
wiley   +1 more source

Differential perforin sensitivity drives lineage-dependent resistance to CAR T-cell killing in blood cancer cell lines. [PDF]

open access: yesBlood Adv
Hodel AW   +8 more
europepmc   +1 more source

Checkpoint-enriched T cells with retained effector-associated features are associated with disease activity in systemic lupus erythematosus. [PDF]

open access: yesFront Immunol
Santana-Sánchez P   +6 more
europepmc   +1 more source

Engineering a dual-antigen mRNA vaccine to restore immune control in chronic hepatitis B. [PDF]

open access: yesNat Commun
Zhang B   +9 more
europepmc   +1 more source

Granzyme A amplifies human neutrophil pyroptosis

open access: yes
Kasperkiewicz P   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy